UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (108) 108
life sciences & biomedicine (107) 107
humans (84) 84
female (40) 40
immunotherapy (36) 36
immunology (30) 30
male (30) 30
oncology (29) 29
cytotoxic t lymphocyte-associated antigen-4 (28) 28
middle aged (26) 26
adult (25) 25
antigens (25) 25
animals (24) 24
ctla-4 antigen (23) 23
ctla-4 antigen - genetics (23) 23
lymphocytes (23) 23
cytotoxic t-lymphocyte-associated antigen-4 (22) 22
polymorphism (22) 22
cytotoxicity (20) 20
meta-analysis (19) 19
genetic aspects (18) 18
genetic predisposition to disease (18) 18
antibodies, monoclonal - therapeutic use (17) 17
cancer (17) 17
melanoma (17) 17
t cells (17) 17
aged (15) 15
ctla-4 antigen - immunology (15) 15
genotype (15) 15
ipilimumab (15) 15
polymorphism, single nucleotide (15) 15
antineoplastic agents - therapeutic use (14) 14
lymphocytes t (14) 14
review (14) 14
case-control studies (13) 13
cytotoxic t lymphocyte associated antigen-4 (13) 13
medicine, research & experimental (13) 13
research & experimental medicine (13) 13
risk factors (13) 13
care and treatment (12) 12
ctla-4 protein (12) 12
gene frequency (12) 12
research (12) 12
antigens, cd - genetics (11) 11
medicine & public health (11) 11
treatment outcome (11) 11
adolescent (10) 10
cytotoxic t lymphocyte-associated antigen 4 (10) 10
gene polymorphism (10) 10
immune checkpoint (10) 10
pharmacology & pharmacy (10) 10
polymorphism, genetic (10) 10
asian continental ancestry group - genetics (9) 9
cell biology (9) 9
chemical and pharmacologic phenomena (9) 9
cytotoxic t-lymphocyte-associated protein 4 (9) 9
dermatology (9) 9
immunotherapy - methods (9) 9
mice (9) 9
t-lymphocytes - immunology (9) 9
tumors (9) 9
antibodies (8) 8
antibodies, monoclonal - adverse effects (8) 8
biochemistry & molecular biology (8) 8
ctla-4 antigen - antagonists & inhibitors (8) 8
gene expression (8) 8
melanoma - drug therapy (8) 8
neoplasms - immunology (8) 8
single nucleotide polymorphism (8) 8
aged, 80 and over (7) 7
antigens, differentiation - genetics (7) 7
antineoplastic agents - adverse effects (7) 7
clinical trials (7) 7
cytokines (7) 7
cytotoxic t-lymphocyte-associated antigen 4 (7) 7
flow cytometry (7) 7
health aspects (7) 7
myasthenia gravis (7) 7
polymerase chain reaction (7) 7
programmed cell death protein 1 (7) 7
programmed death 1 (7) 7
promoter regions, genetic (7) 7
proteins (7) 7
abatacept (6) 6
alleles (6) 6
antigens, cd (6) 6
apoptosis (6) 6
biomedicine (6) 6
chemotherapy (6) 6
child (6) 6
clinical trials as topic (6) 6
cytotoxic t-lymphocyte associated antigen-4 (6) 6
cytotoxic t-lymphocyte associated protein 4 (6) 6
cytotoxic t‐lymphocyte‐associated antigen‐4 (6) 6
general & internal medicine (6) 6
genetic research (6) 6
hemic and immune systems (6) 6
immune checkpoint inhibitors (6) 6
immune system (6) 6
internal medicine (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Tumor biology, ISSN 1010-4283, 4/2014, Volume 35, Issue 4, pp. 2893 - 2903
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) gene polymorphisms have been associated with many autoimmune diseases and malignancy susceptibility, but the relationship between CTLA-4 and cervical cancer is still controversial... 
Cancer Research | Biomedicine | Cytotoxic T lymphocyte-associated antigen-4 | Gene polymorphism | Cervical cancer | Meta-analysis | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Uterine Cervical Neoplasms - etiology | CTLA-4 Antigen - genetics | Female | Risk | Uterine Cervical Neoplasms - genetics | Polymorphism, Genetic | Women | Antigens | Yuan (China) | Analysis | Genes | T cells | Child care | Health aspects | Public health | Lymphocytes | Risk factors | Polymorphism | Index Medicus
Journal Article
Frontiers in pharmacology, ISSN 1663-9812, 11/2019, Volume 10, pp. 1350 - 1350
Immune checkpoint inhibitors (ICIs) that target cytotoxic T lymphocyte antigen 4, programmed cell death-1, and PD-ligand 1 have revolutionized cancer... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Apoptosis | cardiotoxicity | cytotoxic T lymphocyte-associated antigen-4 | programmed cell death protein 1 | immune checkpoint inhibitors | pericarditis | myocarditis
Journal Article